Astrazeneca erwirbt Cincor mit Herz-/Nieren-Medikament Baxdrostat
Von Joe Hoppe LONDON (Dow Jones)--Astrazeneca erwirbt das US-biopharmazeutische Unternehmen Cincor. Die Transaktion hat laut Mitteilung einen Wert bis…
61,750€
0,82%
Echtzeit-Aktienkurs ASTRAZENECA DL-,25 SP.ADR
Bid:
Ask:
Nachrichten zur ASTRAZENECA DL-,25 SP.ADR Aktie
BUSINESS LIVE: AZN buys US firm; Capricorn okays Palliser board picks
Among the companies with reports and trading updates today are AstraZeneca, Capricorn Energy, Vodafone, Boparan, Tortilla Mexican Grill and DeepVerge....…
UPDATE 1-AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal
...(Adds details)
Jan 9 (Reuters) - AstraZeneca said on Monday......…
AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset
AstraZeneca PLC Will Buy CinCor for Cardiorenal Asset...…
AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 billion deal
...(Reuters) - AstraZeneca said on Monday it will acquire U.S.-based......…
AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal
...Jan 9 (Reuters) - AstraZeneca said on Monday it
will acquire U.S......…
CinCor Pharma to be Acquired by AstraZeneca
WALTHAM, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that it has…
AstraZeneca acquire CinCor for cardiorenal asset
9 January 2023 07:00 GMT
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
Acquisition to access global rights to baxdrostat,
a novel…
LBT Innovations (ASX:LBT) partners with AstraZeneca for APAS Pharma development
LBT Innovations (LBT) has been engaged by AstraZeneca to undertake a full…...…
LBT Innovations to partner with AstraZeneca on development of APAS Pharma microbial monitoring product
This content is created by Smallcaps Authors. [Author : Imelda Cotton]
Australian medical technology company LBT Innovations (ASX: LBT) will…
Omicron Subvariant XBB.1.5 Likely Resistant to AstraZeneca (AZN ...
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZenecas COVID drug Evusheld unlikely to neutralize newest variant, FDA says
The Food and Drug Administration late Friday said that AstraZeneca Plc's COVID-19 drug Evusheld may not provide protection against…
AstraZeneca Neutral
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Bank Credit Suisse hat das Kursziel für Astrazeneca von 11000 auf 11800 Pence angehoben,…
Friday’s Top Analyst Upgrades and Downgrades: American Express, AstraZeneca, Coinbase, Comcast, Delta Air Lines, Marathon Oil, Microsoft, Target and More
Fridays top analyst upgrades and downgrades included Ally Financial, American Express, AppLovin, AstraZeneca, Coinbase Global, Cognizant Technology Solutions, Comcast, CME,…
Brazil: return of pressure for vaccine brings back controversy about AstraZeneca in pregnant women
As soon as he took power, the inaugurated president, Lula da Silva (PT), and his health team made clear threats…
AstraZeneca: Ersteinschätzung
Toronto (www.aktiencheck.de) - Rating-Update:
Etzer Darout, Analyst von BMO Capital Markets, startet die Coverage der Aktie von AstraZeneca plc (ISIN: GB0009895292,…
Zoom Appoints Cindy Hoots to Board of Directors
SAN JOSE, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Zoom Video Communications, Inc. (NASDAQ: ZM) announced that it…
AstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDA
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca started at outperform with $82 stock price target at BMO Capital
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA
Sanofi, AstraZeneca Respiratory Treatment Nirsevimab Biologics License Accepted by FDA...…
Form 6-K ASTRAZENECA PLC For: Jan 03
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Total Voting Rights
3 January 2023 15:00 GMT
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
GSK Looking For Under-Appreciated M&A Targets, Not Trying To Be Next Roche Or AstraZeneca
GSK plc (NYSE: GSK) chief commercial officer Luke Miels says the company is looking at M&A targets that are under-appreciated worth…
Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…
Form 6-K ASTRAZENECA PLC For: Dec 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
ADRs End Mostly Lower, AstraZeneca and ABB Trade Actively
ADRs End Mostly Lower, AstraZeneca and ABB Trade Actively...…
Form 6-K ASTRAZENECA PLC For: Dec 28
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Cancer Drug Gets First Japan Nod as Approvals Grow
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
TOP NEWS: AstraZeneca wins approvals for cancer treatments in Japan
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
LONDON BRIEFING: UK strikes continue; AstraZeneca wins Japan approvals
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Imfinzi + Imjudo Approved In Japan For Advanced Liver, Biliary Tract And Lung Cancers
LONDON (dpa-AFX) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Wednesday that its immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab)…
Calquence Japan approval for treatment-naïve CLL
28 December 2022 07:05 GMT
Calquence approved in Japan for adults with
treatment-naïve chronic lymphocytic leukaemia
Calquence significantly increased the time patients lived without…
The Zacks Analyst Blog Highlights Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies
Novo Nordisk, AstraZeneca, Accenture, Chubb and Roper Technologies are part of the Zacks top Analyst Blog....…
Top Research Reports for Novo Nordisk, AstraZeneca & Accenture
Todays Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), AstraZeneca PLC (AZN) and…
ADRs End Higher, AstraZeneca and Carnival Trade Actively
ADRs End Higher, AstraZeneca and Carnival Trade Actively...…
AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs
The European Commission approves AstraZenecas (AZN) two key cancer drugs Lynparza and Imfinzi for expanded use....…
AstraZeneca has two of its cancer drugs approved for use in the EU
The FTSE 100 pharma giant said Imfinzi has been given the green light in the EU for the treatment of…
Form 6-K ASTRAZENECA PLC For: Dec 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca wins two new approvals in EU for cancer drugs
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Imfinzi combo for biliary tract cancer gets approval in EU
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Imfinzi Combination Approved In EU For Advanced Biliary Tract Cancer Treatment
LONDON (dpa-AFX) - British drug major AstraZeneca Plc.s (AZN.L, AZN) Imfinzi (durvalumab) has been approved in the European Union for…
AstraZeneca: Lynparza In Combination With Abiraterone Approved In EU For Prostate Cancer
LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L), on Wednesday, announced that Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone…
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
ABU DHABI, UAE, Dec. 20, 2022 /PRNewswire/ -- Building on the ongoing efforts of the Department of Health – Abu…
Astrazeneca (AZN) Stock Moves -0.69%: What You Should Know
Astrazeneca (AZN) closed the most recent trading day at $67.47, moving -0.69% from the previous trading session....…
ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively
ADRs End Mixed; AstraZeneca, atai Life Sciences Trade Actively...…
AstraZeneca posts mixed results from lung cancer trial
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 6-K ASTRAZENECA PLC For: Dec 19
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting
read more...…
TOP NEWS: AstraZeneca receives host of EU approvals or recommendations
Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…
AstraZeneca: Enhertu Gets CHMP Recommendation For EU Approval For HER2-low Metastatic Breast Cancer
LONDON (dpa-AFX) - British drug major AstraZeneca Plc (AZN.L, AZN) announced Monday that the European Medicines Agencys Committee for Medicinal…